Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors.
López L, Morosi LG, La Terza F, Bourdely P, Rospo G, Amadio R, Piperno GM, Russo V, Volponi C, Vodret S, Joshi S, Giannese F, Lazarevic D, Germano G, Stoitzner P, Bardelli A, Dalod M, Pace L, Caronni N, Guermonprez P, Benvenuti F.
López L, et al. Among authors: germano g.
Nat Commun. 2024 Mar 13;15(1):2280. doi: 10.1038/s41467-024-46685-y.
Nat Commun. 2024.
PMID: 38480738
Free PMC article.